Weekly NIH Funding Opportunities and Notices NIH Guide for Grants and Contracts Table of Contents (TOC)

Size: px

Start display at page:

Download "Weekly NIH Funding Opportunities and Notices NIH Guide for Grants and Contracts Table of Contents (TOC)"

Paul Hancock
5 years ago
Views:

1 Weekly NIH Funding Opportunities and Notices NIH Guide for Grants and Contracts Table of Contents (TOC) All NIH Funding Opportunities and Notices Notices Additional Short-Term Administrative Relief to Institutions Impacted by Hurricanes Harvey, Irma, and Maria (NOT-OD ) National Institutes of Health Reminder: Annual Reports to the Office of Laboratory Animal Welfare due January 31, 2018 (NOT-OD ) National Institutes of Health Request for Information on the Office of Disease Prevention Strategic Plan for Fiscal Years (FY) (NOT-OD ) Office of Disease Prevention National Institutes of Health Notice of NIA Participation in PAR : "Short-term Mentored Career Enhancement Awards for Mid- Career Investigators to Integrate Basic Behavioral and Social Sciences (K18 Clinical Trial Required)" (NOT-AG ) Notice of NIAMS' Participation in PA "NIH Pathway to Independence Award (Parent K99/R00 - Independent Clinical Trial Not Allowed" (NOT-AR ) National Institute of Arthritis and Musculoskeletal and Skin Diseases Notice of Clarification on Award Project Period for PAR "Revision Applications for Validation of Biomarker Assays Developed Through NIH-Supported Research Grants (R01)" (NOT-CA ) Notice of Intent to Publish a Funding Opportunity Announcement for Synthetic Psychoactive Drugs and Strategic Approaches to Counteract Their Deleterious Effects (R01 ) (NOT-DA ) NIBIB Notice to Clarify the Types of Clinical Trials NIBIB Will Support Under PAR , NIBIB Biomedical Technology Resource Centers (P41 Clinical Trial Optional) (NOT-EB ) Notice to Clarify the Types of Clinical Trials NIBIB Will Support Under PAR Bioengineering Research Grants (BRG) (R01 Clinical Trial Optional) (NOT-EB ) Notice of Participation of the in PA "Independent Scientist Award (Parent K02 - Independent Clinical Trial Required)" (NOT-ES ) Notice of Participation of the in PA " Mentored Clinical Scientist Research Career Development Award (Parent K08 - Independent Clinical Trial Required)" (NOT-ES ) Notice of Participation of the in PA "Mentored Patient-Oriented Research Career Development Award (Parent K23 - Clinical Trial Required)" (NOT-ES )

2 Notice of Participation of the in PA "Midcareer Investigator Award in Patient-Oriented Research (Parent K24 Clinical Trial Required)" (NOT-ES ) Notice of Cancellation of the October 2018 Receipt Date for RFA-FD (NOT-FD ) Food and Drug Administration Office of Orphan Products Development Reminder of Required Letter of Support for PAR "Maximizing Investigators Research Award (R35)" (NOT-GM ) National Institute of General Medical Sciences Notice of Change in Eligibility for PAR "Maximizing Investigators Research Award (R35)" (NOT-GM ) National Institute of General Medical Sciences NHLBI Announces Participation in PA "Ruth L. Kirschstein National Research Service Award (NRSA) Short-Term Research Training Grant (Parent T35)" (NOT-HL ) National Heart, Lung, and Blood Institute Collaborative Research in Computational Neuroscience (CRCNS) NSFInnovative Approaches to Science and Engineering Research on Brain Function (NOT-MH ) Notice of NINDS' Participation in PA "Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grant (Parent T32)" (NOT-NS ) Notice of (NINDS) and National Institute on Drug Abuse (NIDA) Interest in Blueprint Neurotherapeutic Network Applications Directed at Small Molecule Non-Addictive Pain Therapies (NOT-NS ) Notice of Clarification of NINDS Statement of interest for "Bioengineering Research Grants (BRG) (R01 Clinical Trial Optional)" (NOT-NS )

3 Requests for Applications Interaction of HIV Infection and Alcohol Abuse on Central Nervous System Morbidity Limited Competition (U01 Clinical Trial Not Allowed) (RFA-AA ) Application Receipt Date(s): February , by 5:00 PM local time of applicant organization. All types of non-aids accepted in response to this funding opportunity announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. From Association to Function in the Alzheimers Disease Post-Genomics Era (R01 - Clinical Trial Not Allowed) (RFA-AG ) Application Receipt Date(s): March 28, 2018, by 5:00 PM local time of applicant organization. All types of non-aids Exosomes: From Biogenesis and Secretion to the Early Pathogenesis of Alzheimer's Disease (R01 - Clinical Trial Not Allowed) (RFA-AG ) Application Receipt Date(s): March 26, 2018, by 5:00 PM local time of applicant organization. All types of non-aids Pragmatic Trials of Managing Multimorbidity in Alzheimers Disease (R01 Clinical Trial Required) (RFA-AG ) Application Receipt Date(s): March 26, 2018, by 5:00 PM local time of applicant organization. All types of non-aids Interdisciplinary Research to Understand the Complex Biology of Resilience to Alzheimers Disease Risk (R01 - Clinical Trial Not Allowed) (RFA-AG ) Application Receipt Date(s): March 26, 2018), by 5:00 PM local time of applicant organization. All types of non-aids Discovery and Biological Signatures of Diet Derived Microbial Metabolites (R01 Clinical Trial Optional) (RFA-AT ) Application Receipt Date(s): March 19, 2018, by 5:00 PM local time of applicant organization. All types of non-aids accepted for this Funding Opportunity Announcement Applicants are encouraged to apply early to allow adequate time Development of Medications to Prevent and Treat Opioid Use Disorders and Overdose (UG3/UH3) (Clinical Trials Optional) (RFA-DA ) Application Receipt Date(s): Applications will be accepted on a rolling basis, beginning on January 25, 2018 NIDCR Dental Specialty and PhD Program (DSPP)(K12-Clinical Trials Not Allowed) (RFA-DE ) National Institute of Dental and Craniofacial Research Application Receipt Date(s): February 09, 2018, by 5:00 PM local time of applicant organization. All types of non-aids

4 Microphysiological Systems (MPS) for Modeling Diabetes (UG3/UH3 Clinical Trial Not Allowed) (RFA-DK ) National Institute of Diabetes and Digestive and Kidney Diseases National Center for Advancing Translational Sciences Application Receipt Date(s): March 20, 2018), by 5:00 PM local time of applicant organization. All types of non-aids applications allowed for this funding opportunity announcement are due on this date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. Non-Invasive Diagnostics to Improve Gynecologic Health (R43/R44 - Clinical Trial Optional) (RFA-HD ) Application Receipt Date(s): March 30, 2018, by 5:00 PM local time of applicant organization. Deciphering the Molecular Landscape of Lung Aging in Humans (U01 - Clinical Trial Not Allowed) (RFA-HL ) National Heart, Lung, and Blood Institute Application Receipt Date(s): February 27, 2018, by 5:00 PM local time of applicant organization. All types of non-aids applications allowed for this funding opportunity announcement are due on this date. BRAIN Initiative: Targeted BRAIN Circuits Planning Projects TargetedBCPP (R34 - Clinical Trials Not Allowed) (RFA-NS ) Office of Behavioral and Social Science Research Office of Research on Women's Health Application Receipt Date(s): March 15, 2018; July 17, 2018; July 15, 2019, by 5:00 PM local time of applicant organization. All types of non-aids applications allowed for this funding opportunity announcement are due on these dates. BRAIN Initiative: Biology and Biophysics of Neural Stimulation (R01 - Clinical Trials Optional) (RFA-NS ) Application Receipt Date(s): February 23, 2018, June 6, 2018, October 4, 2018, February 6, 2019, June 4, 2019, October 4, 2019, February 6, 2020, June 4, 2020, and October 6, 2020, by 5:00 PM local time of applicant organization. All types of non-aids applications allowed for this funding opportunity announcement are due on these dates.

5 Program Announcements Studies in Neonatal and Pediatric Resuscitation (R01 Clinical Trial Optional) (PA ) Studies in Neonatal and Pediatric Resuscitation (R03 - Clinical Trial Optional) (PA ) Using Information Technology to Support Systematic Screening and Treatment of Depression in Cancer (R21 Clinical Trial Optional) (PA ) Using Information Technology to Support Systematic Screening and Treatment of Depression in Cancer (R01 Clinical Trial Optional) (PA ) Academic Research Enhancement Award in Diseases within the Mission of NIDDK (R15 - Clinical Trial Required) (PA ) National Institute of Diabetes and Digestive and Kidney Diseases Administrative Supplements to NCI Grant and Cooperative Agreement Awards to Support Collaborations with the PDX Development and Trial Centers Research Network (PDXNet)(Admin Suppl - Clinical Trial Not Allowed) (PA ) Application Receipt Date(s): March 1, 2018, by 5:00 PM local time of applicant organization. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. End-of-Life and Palliative Care Health Literacy: Improving Outcomes in Serious, Advanced Illness (R01 Clinical Trial Optional) (PA ) AIDS applications allowed for this funding opportunity announcement are due on these dates. The first standard application due date for this FOA is _June 5, 2018_. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the

6 End-of-Life and Palliative Care Health Literacy: Improving Outcomes in Serious, Advanced Illness (R21 Clinical Trial Optional) (PA ) AIDS applications allowed for this funding opportunity announcement are due on these dates. The first standard application due date for this FOA is _June 16, 2018 Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the Human Subjects Mechanistic and Minimal Risk Studies (R21 Clinical Trial Optional) (PA ) Application Receipt Date(s): Standard dates apply by 5:00 PM local time of applicant organization. All types of non- Advancing the Science of Geriatric Palliative Care (R01 - Clinical Trial Optional) (PA ) National Heart, Lung, and Blood Institute National Institute on Minority Health and Health Disparities AIDS applications allowed for this funding opportunity announcement are due on these dates. The first standard application due date for this FOA is February 5, Advancing the Science of Geriatric Palliative Care (R21 - Clinical Trial Optional) (PA ) National Institute on Minority Health and Health Disparities AIDS applications allowed for this funding opportunity announcement are due on these dates. The first standard application due date for this FOA is February 16, Academic Research Enhancement Award (Parent R15 Clinical Trial Not Allowed) (PA ) National Institutes of Health National Human Genome Research Institute National Heart, Lung, and Blood Institute National Institute of Allergy and Infectious Diseases National Institute of Arthritis and Musculoskeletal and Skin Diseases National Institute of Dental and Craniofacial Research National Institute of Diabetes and Digestive and Kidney Diseases National Institute of General Medical Sciences National Institute on Minority Health and Health Disparities National Library of Medicine

7 Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs AIDS applications allowed for this funding opportunity announcement are due on these dates. The first standard due date for this FOA is February 25, Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the NIDCR Dual Degree Dentist Scientist Pathway to Independence Award (K99/R00-Clinical Trial Required) (PAR ) National Institute of Dental and Craniofacial Research Application Receipt Date(s): Standard dates, by 5:00 PM local time of applicant organization. All types of non-aids applications allowed for this funding opportunity announcement are due on these dates. NIBIB Exploratory/Developmental Research Grant Program (R21) (Clinical Trial Optional) (PAR ) AIDS applications allowed for this funding opportunity announcement are due on these dates. Synthetic Biology for Engineering Applications (R01) (Clinical Trial Optional) (PAR ) AIDS applications allowed for this funding opportunity announcement are due on these dates. NIDCD Early Career Research(ECR) Award (R21 - Clinical Trials Optional) (PAR ) Application Receipt Date(s): February 27, 2018; June 26, 2018; October 26, 2018; February 26, 2019; June 26, 2019; October 28, 2019; February 26, 2020; June 26, 2020; October 27, 2020, by 5:00 PM local time of applicant organization. All types of non-aids applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the Device-Based Treatments for Substance Use Disorders (UG3/UH3) (Clinical Trial Optional) (PAR ) Application Receipt Date(s): March 27, 2018; July 24, 2018; March 27, 2019; July 24, 2019; March 27, 2020; July 24, 2020 Sleep disorders and circadian clock disruption in Alzheimers disease and other dementias of aging (R01 Clinical Trial Not Allowed) (PAR ) Application Receipt Date(s): The first application due date is March 26, 2018, by 5:00 PM local time of the applicant organization. Subsequent due dates for new applications are June 6, 2018; October 7, 2018; February 7, 2019; June 7, 2019; October 7, 2019; February 7, 2020; June 8, 2020; and October 8, 2020, by 5:00 PM local time of the applicant organization. Due dates for revision and resubmission applications are July 7, 2018; November 7, 2018; March 7, 2019; July 8, 2019; November 7, 2019; March 6, 2020; July 7, 2020; and November 6, 2020, by 5:00 PM local time of applicant organization. All types of non-aids applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the

8 BRAIN Initiative: Development, Optimization, and Validation of Novel Tools and Technologies for Neuroscience Research (SBIR)(R43/R44 Clinical Trial Not Allowed) (PAR ) Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. BRAIN Initiative: Development, Optimization, and Validation of Novel Tools and Technologies for Neuroscience Research (STTR)(R41/R42 Clinical Trial Not Allowed) (PAR ) Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * You have received this information as a result of being subscribed to the UTHSCSA Office of Sponsored Programs fundinginfo2 ListServ. To remove yourself from this list, visit the Subscriber's Corner in the List Archives and follow the onscreen instructions to log in and manage your list subscriptions. * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *

Weekly NIH Funding Opportunities and Notices NIH Guide for Grants and Contracts Table of Contents (TOC)

Weekly NIH Funding Opportunities and Notices NIH Guide for Grants and Contracts 08-24-2018 Table of Contents (TOC) Notices Notice of Webinar for PAR 18 307 "Developing Interventions for Health Enhancing